EPIX - ESSA Pharma Inc.

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 6.08

Open

$ 6.14

Bid

$ 5.86 x 100

Ask

$ 0.00 x 0

Day's Range

$ 5.80 - $ 6.14

52 Week Range

$ 2.56 - $ 11.67

Volume

178,467

Average Volume

Market Cap

268.31M

Beta (5Y Monthly)

$ 1.22

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-13-2024	12-31-2023	10-Q
2	12-12-2023	09-30-2023	10-K
3	08-08-2023	06-30-2023	10-Q
4	05-09-2023	03-31-2023	10-Q
5	02-07-2023	12-31-2022	10-Q
6	12-13-2022	09-30-2022	10-K
7	08-04-2022	06-30-2022	10-Q
8	05-10-2022	03-31-2022	10-Q
9	02-03-2022	12-31-2021	10-Q
10	11-18-2021	09-30-2021	10-K
11	08-16-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	02-11-2021	12-31-2020	10-Q
14	12-15-2020	09-30-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

ESSA Pharma: Q1 Earnings Insights
02/13/2024 14:10:05

1000-invested-in-this-stock-5-years-ago-would-be-worth-2100-today

$1000 Invested In This Stock 5 Years Ago W...
01/30/2024 17:06:11

Booz Allen Hamilton Posts Upbeat Results, ...
01/26/2024 15:30:51

U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday.

whats-going-on-with-prostate-cancer-focused-essa-pharma-stock-today

What's Going On With Prostate Cancer Focus...
01/26/2024 13:51:35

ESSA Pharma shares fell 22.6% at $6.80 yesterday. Explore masofaniten's promising Phase 1/2 results in prostate cancer trea...

Why Humana Shares Are Trading Lower By Ove...
01/25/2024 19:52:24

Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earning...

ESSA Pharma Presents Updated Phase 1 Masof...
01/25/2024 15:01:55

Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in patients...

applied-digital-essa-pharma-and-other-big-stocks-moving-higher-in-tuesdays-pre-market-session

Applied Digital, ESSA Pharma And Other Big...
01/16/2024 10:53:04

U.S. stock futures were lower this morning, with the Nasdaq futures falling around 100 points on Tuesday. Here are some big st...

Oppenheimer Reiterates Outperform on ESSA ...
12/13/2023 16:36:18

Oppenheimer analyst Mark Breidenbach reiterates ESSA Pharma (NASDAQ:EPIX) with a Outperform and maintains $17 price target.

ESSA Pharma Q4 EPS $(0.12) Up From $(0.14)...
12/12/2023 12:05:47

ESSA Pharma (NASDAQ:EPIX) reported quarterly losses of $(0.12) per share. This is a 14.29 percent increase over losses of $(0.1...

Recap: ESSA Pharma Q4 Earnings
12/12/2023 12:05:05

Essa Pharma Announced It May Offer And Sel...
11/06/2023 11:10:28

https://www.sec.gov/Archives/edgar/data/1633932/000110465923114419/tm2326295d4_424b5.htm

ESSA Pharma Announced Data Combination Of ...
10/21/2023 13:17:50

ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ:EPIX), a clinical-stage pharmaceutical company focused on d...

why-streamline-health-solutions-shares-are-trading-lower-by-over-68-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Streamline Health Solutions Shares Are...
10/16/2023 17:09:53

Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.

why-contrafect-shares-are-trading-higher-by-around-30-here-are-20-stocks-moving-premarket

Why ContraFect Shares Are Trading Higher B...
10/16/2023 12:47:12

Gainers LQR House Inc. (NASDAQ: LQR) shares surged 109% to $0.3602 in pre-market trading after the company delivered inaugura...

ESSA Pharma Announces Initiation Of Phase ...
09/18/2023 11:02:41

Watching ESSA Pharma; Zacks Small-Cap Rese...
08/14/2023 16:12:38

https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_08142023_EPIX_Bautz.pdf

Oppenheimer Reiterates Outperform on ESSA ...
08/09/2023 13:50:45

Oppenheimer analyst Mark Breidenbach reiterates ESSA Pharma (NASDAQ:EPIX) with a Outperform and maintains $17 price target.

Oppenheimer Assumes ESSA Pharma at Outperf...
06/26/2023 10:48:58

Oppenheimer analyst Mark Breidenbach assumes ESSA Pharma (NASDAQ:EPIX) with a Outperform rating and announces Price Target o...

Watching ESSA Pharma; Zacks Small-Cap Rese...
05/18/2023 14:04:39

https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_05182023_EPIX_Bautz.pdf

ESSA Pharma: Q2 Earnings Insights
05/09/2023 14:05:29

ESSA Pharma (NASDAQ:EPIX) reported its Q2 earnings results on Tuesday, May 9, 2023 at 07:00 AM. Here's what investors need ...